258 related articles for article (PubMed ID: 20138719)
1. Male breast cancer: an update in diagnosis, treatment and molecular profiling.
Onami S; Ozaki M; Mortimer JE; Pal SK
Maturitas; 2010 Apr; 65(4):308-14. PubMed ID: 20138719
[TBL] [Abstract][Full Text] [Related]
2. Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.
Deb S; Jene N; ; Fox SB
BMC Cancer; 2012 Nov; 12():510. PubMed ID: 23146383
[TBL] [Abstract][Full Text] [Related]
3. Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.
Gargiulo P; Pensabene M; Milano M; Arpino G; Giuliano M; Forestieri V; Condello C; Lauria R; De Placido S
BMC Cancer; 2016 Jul; 16():375. PubMed ID: 27377827
[TBL] [Abstract][Full Text] [Related]
4. Male Breast Cancer (MBC) - A Review.
AlFehaid M
Pol Przegl Chir; 2023 Dec; 95(6):24-30. PubMed ID: 38058163
[TBL] [Abstract][Full Text] [Related]
5. An updated review of epidemiology, risk factors, and management of male breast cancer.
Khan NAJ; Tirona M
Med Oncol; 2021 Mar; 38(4):39. PubMed ID: 33721121
[TBL] [Abstract][Full Text] [Related]
6. [Breast cancer in male].
Würstlein R; Hesse A; König A; Schulte-Vorwick F; Schrodi S; Ditsch N; Mahner S; Harbeck N
MMW Fortschr Med; 2017 Dec; 159(21-22):67-72. PubMed ID: 29230744
[No Abstract] [Full Text] [Related]
7. Male breast cancer.
Reis LO; Dias FG; Castro MA; Ferreira U
Aging Male; 2011 Jun; 14(2):99-109. PubMed ID: 21204612
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P
Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974
[TBL] [Abstract][Full Text] [Related]
9. 19. Male breast cancer: aetiology, genetics and clinical management.
Tischkowitz MD; Hodgson SV; Fentiman IS
Int J Clin Pract; 2002 Dec; 56(10):750-4. PubMed ID: 12510948
[TBL] [Abstract][Full Text] [Related]
10. Male breast cancer: a special therapeutic problem. Anything new? (Review).
Gennari R; Curigliano G; Jereczek-Fossa BA; Zurrida S; Renne G; Intra M; Galimberti V; Luini A; Orecchia R; Viale G; Goldhrisch A; Veronesi U
Int J Oncol; 2004 Mar; 24(3):663-70. PubMed ID: 14767551
[TBL] [Abstract][Full Text] [Related]
11. Triple-negative breast cancer and poly(ADP-ribose) polymerase inhibitors.
Park Y; Moriyama A; Kitahara T; Yoshida Y; Urita T; Kato R
Anticancer Agents Med Chem; 2012 Jul; 12(6):672-7. PubMed ID: 22263793
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
Amirifard N; Sadeghi E
Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
[TBL] [Abstract][Full Text] [Related]
13. HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures.
Davies H; Glodzik D; Morganella S; Yates LR; Staaf J; Zou X; Ramakrishna M; Martin S; Boyault S; Sieuwerts AM; Simpson PT; King TA; Raine K; Eyfjord JE; Kong G; Borg Å; Birney E; Stunnenberg HG; van de Vijver MJ; Børresen-Dale AL; Martens JW; Span PN; Lakhani SR; Vincent-Salomon A; Sotiriou C; Tutt A; Thompson AM; Van Laere S; Richardson AL; Viari A; Campbell PJ; Stratton MR; Nik-Zainal S
Nat Med; 2017 Apr; 23(4):517-525. PubMed ID: 28288110
[TBL] [Abstract][Full Text] [Related]
14. Male breast cancer is not congruent with the female disease.
Fentiman IS
Crit Rev Oncol Hematol; 2016 May; 101():119-24. PubMed ID: 26989051
[TBL] [Abstract][Full Text] [Related]
15. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
Silvestri V; Zelli V; Valentini V; Rizzolo P; Navazio AS; Coppa A; Agata S; Oliani C; Barana D; Castrignanò T; Viel A; Russo A; Tibiletti MG; Zanna I; Masala G; Cortesi L; Manoukian S; Azzollini J; Peissel B; Bonanni B; Peterlongo P; Radice P; Palli D; Giannini G; Chillemi G; Montagna M; Ottini L
Cancer; 2017 Jan; 123(2):210-218. PubMed ID: 27648926
[TBL] [Abstract][Full Text] [Related]
16. Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population.
Li D; Shi Y; Li A; Cao D; Su H; Yang H; Zhi Q; Yang Y; Lan Z; Zhou T; You X; Hu G
Breast Cancer; 2020 Nov; 27(6):1158-1167. PubMed ID: 32566972
[TBL] [Abstract][Full Text] [Related]
17. Understanding and management of male breast cancer: a critical review.
Pant K; Dutta U
Med Oncol; 2008; 25(3):294-8. PubMed ID: 18074245
[TBL] [Abstract][Full Text] [Related]
18. Special considerations in the evaluation and management of breast cancer in men.
Massarweh SA; Choi GL
Curr Probl Cancer; 2016; 40(2-4):163-171. PubMed ID: 27793424
[TBL] [Abstract][Full Text] [Related]
19. How to treat male breast cancer.
Czene K; Bergqvist J; Hall P; Bergh J
Breast; 2007 Dec; 16 Suppl 2():S147-54. PubMed ID: 18210656
[TBL] [Abstract][Full Text] [Related]
20. Male breast carcinoma: increased awareness needed.
White J; Kearins O; Dodwell D; Horgan K; Hanby AM; Speirs V
Breast Cancer Res; 2011 Sep; 13(5):219. PubMed ID: 22017761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
